Different comparator batches [Regulatives / Guidelines]

posted by dshah  – India, 2025-07-29 10:37 (309 d 23:26 ago) – Posting: # 24418
Views: 2,905

Hi Jansari!

There were few presentation by FDA about using more than one RLD in a single BE study during Covid period. There can be multiple challenges like - assay difference, dissolution difference and anticipated additional variability which may increase the risk.

Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
463 visitors (0 registered, 463 guests [including 19 identified bots]).
Forum time: 10:04 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5